X4 Pharmaceuticals (XFOR) Gains from Investment Securities (2017 - 2024)
X4 Pharmaceuticals' (XFOR) quarterly Gains from Investment Securities came in at $1.9 million in Q3 2024, up 107.41% on a YoY basis from $898714.3 in Q4 2023, and up 109.22% quarter-over-quarter from -$20.2 million in Q2 2024.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Gains from Investment Securities (2017 - 2024) Analysis & Trends
X4 Pharmaceuticals (XFOR) has reported Gains from Investment Securities for 3 consecutive years, with $1.9 million the latest figure, recorded in Q3 2024.
- For the quarter ending Q3 2024, Gains from Investment Securities rose 107.41% year-over-year to $1.9 million; the trailing twelve-month figure through Sep 2024 stood at -$29.8 million (down 3905.38% YoY), and the FY2017 full-year result was $31000.0, up 179.49% from the prior year.
- Gains from Investment Securities grew to $1.9 million in Q3 2024 per XFOR's latest filing, from -$20.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $29.9 million in Q2 2023 and bottomed at -$25.2 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | X4 Pharmaceuticals | 510.43 Mn | 315.33 Mn | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | -20.22 Mn |
| Mar 31, 2024 | 13.76 Mn |
| Sep 30, 2023 | -25.16 Mn |
| Jun 30, 2023 | 29.86 Mn |
| Mar 31, 2023 | -5.44 Mn |
| Dec 31, 2017 | 47,000.00 |
| Sep 30, 2017 | -5,000.00 |
| Jun 30, 2017 | -11,000.00 |